HomePYXS • NASDAQ
add
Pyxis Oncology Inc
Previous close
$1.09
Day range
$1.03 - $1.08
Year range
$0.84 - $5.39
Market cap
65.29M USD
Avg Volume
530.85K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2024info | Y/Y change |
---|---|---|
Revenue | 0.00 | — |
Operating expense | 18.39M | 6.98% |
Net income | -35.57M | -128.06% |
Net profit margin | — | — |
Earnings per share | -0.26 | 20.55% |
EBITDA | -17.84M | -8.12% |
Effective tax rate | 5.73% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 126.93M | 6.40% |
Total assets | 157.18M | -9.52% |
Total liabilities | 36.43M | -24.14% |
Total equity | 120.75M | — |
Shares outstanding | 61.59M | — |
Price to book | 0.54 | — |
Return on assets | -26.09% | — |
Return on capital | -29.18% | — |
Cash Flow
Net change in cash
(USD) | Dec 2024info | Y/Y change |
---|---|---|
Net income | -35.57M | -128.06% |
Cash from operations | -19.29M | -26.46% |
Cash from investing | 26.66M | 160.63% |
Cash from financing | 50.00K | 300.00% |
Net change in cash | 7.42M | 246.84% |
Free cash flow | -12.33M | -43.02% |
About
Founded
2018
Headquarters
Website
Employees
44